Prometheus Biosciences (RXDX) Competitor Comparison
We are evaluating the key criteria listed to compare Prometheus Biosciences (RXDX) against its competitors in the Biotechnology industry.
Market Capitalization
18 / 368Gross Profits
240 / 278Total Revenue
208 / 300EBITDA
260 / 337Free Cashflow
266 / 352Quick Ratio
7 / 357Earnings per Share
271 / 359Dividend yield
0 / 6Total Cash
39 / 358Performance 3 years
5 / 368Performance 5 years
13 / 368Performance 10 years
15 / 368Linearity 3 years
362 / 368Linearity 5 years
358 / 368Linearity 10 years
356 / 368Total Rank
234 / 368Dividend Rank
243 / 368Valuation Rank
280 / 368Piotroski Rank
110 / 368Muliplier Rank
182 / 368Linearity 5 years - RXDX ranking 358 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.